Arcadia Biosciences (RKDA) Other Operating Expenses (2014 - 2025)

Arcadia Biosciences has reported Other Operating Expenses for 12 years, with the latest figure at $750000.0 in Q1 2025.

• For the quarter ending Q1 2025, Other Operating Expenses changed N/A year-over-year to $750000.0; the trailing twelve-month figure through Dec 2025 stood at $750000.0 (down 81.25% YoY), and the FY2025 full-year result was $750000.0, down 81.25% from the prior year.
• Other Operating Expenses for Q1 2025 stood at $750000.0, down from $4.0 million in the prior quarter.
• The five-year high for Other Operating Expenses was $4.0 million in Q2 2024, with the low at -$5.4 million in Q2 2021.
• Historically, Other Operating Expenses has averaged -$66777.8 across 5 years, with a median of $58000.0 in 2022.
• Annual changes were most pronounced in 2021 — Other Operating Expenses sank 106.44% — and 2022, when it soared 101.07%.
• Arcadia Biosciences' Other Operating Expenses stood at -$480000.0 in 2021, then soared by 85.0% to -$72000.0 in 2022, then soared by 126.39% to $19000.0 in 2023, then soared by 20952.63% to $4.0 million in 2024, then plunged by 81.25% to $750000.0 in 2025.
• The last three Other Operating Expenses figures came in at $750000.0 (Q1 2025), $4.0 million (Q2 2024), and $19000.0 (Q1 2023), per Business Quant data.